Apogee Therapeutics, Inc Common Stock
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -36 | -29 | ||
EBITDA | -58,638 | -44,086 | -38,152 | -31,735 |
EBIT | -58,686 | -44,122 | -38,181 | -68,890 |
Net Income | -49,018 | -33,816 | -32,094 | -31,735 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -43,275 | -29,351 | -31,987 | -29,921 |
Cash | 118,780 | 307,299 | 485,457 | 118,316 |
Basic Shares | 56,795 | 56,515 | 50,189 | 50,655 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 |
|---|---|---|
Revenue | $0 | $0 |
EBITDA | -83,985 | -30,727 |
EBIT | -93,003 | -64,247 |
Net Income | -83,985 | -39,785 |
Net Change In Cash | 0 | 0 |
Free Cash Flow | -74,928 | -16,427 |
Cash | 118,316 | 151,890 |
Basic Shares | 25,005,774 | 50,674 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.86 |
2024-06-30 | -$0.60 |
2024-03-31 | -$0.64 |
2023-12-31 | -$0.32 |
